MedPath

Treatment of H. pylori Infection for Resistance of Double eradications

Phase 4
Conditions
The patients after unseccessful 1st and 2nd line eradication treatment
Registration Number
JPRN-UMIN000012091
Lead Sponsor
SAMURAI Study
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
234
Inclusion Criteria

Not provided

Exclusion Criteria

a history of antimicrobials after 2nd-line eradcation a history of PPI use 1 week before entry a history of NSAID or steriod use 1 month before entry a history of gastrointestinal surgery, the severe liver, renal, and cardiopulmonary dysfunctions a history of drug allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath